“I believe that the healthcare industry presents itself as a very defensive growth asset (to investors), especially in Southeast Asia. Things are looking quite good,” says Kiat Lim, executive vice-chairman of TMG, in an interview with The Edge Singapore.
The Covid-19 surge in demand for healthcare services may be over but the industry is set to continue its growth trajectory, thanks to rising income and standards of living as well as the growth of urban populations, particularly in Asia.
As Thomson Medical Group (TMG) has stopped supporting the Singapore government in its battle against Covid-19 by setting up testing centres, vaccination centres and isolation facilities, the group is now falling back on the business it knows best — the medical speciality of women’s and children’s health.
